These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
589 related articles for article (PubMed ID: 2522978)
1. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo. Cadroy Y; Horbett TA; Hanson SR J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin. Cadroy Y; Harker LA; Hanson SR J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985 [TBL] [Abstract][Full Text] [Related]
3. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis. Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343 [TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effects of synthetic pentasaccharide with high affinity for plasma antithrombin III in non-human primates. Cadroy Y; Hanson SR; Harker LA Thromb Haemost; 1993 Oct; 70(4):631-5. PubMed ID: 8115989 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic modification of acute vascular graft thrombosis. Hanson SR; Reidy MA; Hattori A; Harker LA Scan Electron Microsc; 1982; (Pt 2):773-9. PubMed ID: 6762650 [TBL] [Abstract][Full Text] [Related]
7. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition. Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274 [TBL] [Abstract][Full Text] [Related]
8. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model. Cadroy Y; Houghten RA; Hanson SR J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221 [TBL] [Abstract][Full Text] [Related]
9. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789 [TBL] [Abstract][Full Text] [Related]
10. In vivo inhibition of acute platelet-dependent thrombosis in a baboon model by Bay U3405, a thromboxane A2-receptor antagonist. Kotzé HF; Lamprecht S; Badenhorst PN; van Wyk V; Roodt JP; Alexander K Thromb Haemost; 1993 Oct; 70(4):672-5. PubMed ID: 8115994 [TBL] [Abstract][Full Text] [Related]
11. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma. Yasuba H; Chihara J; Kino T; Satake N; Oshima S J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572 [TBL] [Abstract][Full Text] [Related]
12. Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood. Barstad RM; Kierulf P; Sakariassen KS Thromb Haemost; 1996 Apr; 75(4):685-92. PubMed ID: 8743200 [TBL] [Abstract][Full Text] [Related]
13. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases]. Murakoshi T Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. Badimon L; Turitto V; Rosemark JA; Badimon JJ; Fuster V J Lab Clin Med; 1987 Dec; 110(6):706-18. PubMed ID: 3681113 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin. Kyrle PA; Westwick J; Scully MF; Kakkar VV; Lewis GP Thromb Haemost; 1987 Feb; 57(1):62-6. PubMed ID: 2954260 [TBL] [Abstract][Full Text] [Related]
16. Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood. Badimon L; Badimon JJ; Rand J; Turitto VT; Fuster V J Lab Clin Med; 1987 Nov; 110(5):634-47. PubMed ID: 3312444 [TBL] [Abstract][Full Text] [Related]
17. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy. Roy MS; Podgor MJ; Rick ME Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258 [TBL] [Abstract][Full Text] [Related]
18. Objective assessment of heparin requirements for hemodialysis in humans. Ireland H; Lane DA; Curtis JR J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409 [TBL] [Abstract][Full Text] [Related]
19. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment. Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788 [TBL] [Abstract][Full Text] [Related]
20. Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions. Roald HE; Barstad RM; Kierulf P; Skjørten F; Dickinson JP; Kieffer G; Sakariassen KS Thromb Haemost; 1994 May; 71(5):655-62. PubMed ID: 8091395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]